Circulating tumor protein markers, such as carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC), cytokeratin 19 fragment antigen (CYFRA21-1), can also act as noninvasive biomarkers to improve early diagnosis of NSCLC (8). This evidence concerns the gene CEACAM5 and neoplasm.